In some Bacillus species, including Bacillus subtilis, the coat is the outermost layer of the spore. In others, such as the Bacillus cereus family, there is an additional layer that envelops the coat, called the exosporium. In the case of Bacillus anthracis, a series of fine hair-like projections, also referred to as a "hairy" nap, extends from the exosporium basal layer. The exact role of the exosporium in B. anthracis, or for any of the Bacillus species possessing this structure, remains unclear. However, it has been assumed that the exosporium would play some role in infection for B. anthracis, because it is the outermost structure of the spore and would make initial contact with host and immune cells during infection. Therefore, the exosporium has been a topic of great interest, and over the past decade much progress has been made to understand its composition, biosynthesis, and potential roles. Several key aspects of this spore structure, however, are still debated and remain undetermined. Although insights have been gained on the interaction of exosporium with the host during infection, the exact role and significance of this complex structure remain to be determined. Furthermore, because the exosporium is a highly antigenic structure, future strategies for the next-generation anthrax vaccine should pursue its inclusion as a component to provide protection against the spore itself during the initial stages of anthrax. FIGURE 1 Electron micrographs of B. subtilis, B. anthracis, and B. megaterium spores. The spore coat (white bar) or exosporium (black bar) as present is labeled for the various species. The arrow indicates the presence of a crust on the B. subtilis spore. The B. subtilis micrograph is courtesy of Adam Driks, Stritch School of Medicine, Loyola University Chicago, Maywood, IL.
In some Bacillus species, including Bacillus subtilis, the coat and a glycoprotein layer referred to as the spore crust are the outermost layer of the spore (Fig. 1) . These spore structures are discussed in more detail in Driks and Eichenberger (108) . In others, such as the Bacillus cereus family, there is an additional layer that envelops the coat, called the exosporium, which is distinct from the crust. In the case of Bacillus anthracis, one of the three pathogenic species of the B. cereus family, a series of fine hair-like projections, also referred to as a "hair-like" nap, extends from the exosporium basal layer (1-4) ( Fig. 1 ). Other exosporium-producing Bacillus species, such as Bacillus megaterium, lack this "hairy" nap ( Fig. 1 ). Separating the exosporium from the rest of the spore structure is an area referred to as the interspace (5) .
The exact role of the exosporium in B. anthracis, or for any of the Bacillus species possessing this structure, remains unclear. However, it has been assumed that the exosporium would play some role in infection for B. anthracis because it is the outermost structure of the spore and would make initial contact with host and immune cells during infection. In addition, because the spores are present in soil, the exosporium will interact with environmental material and other organisms. Therefore, the exosporium has been a topic of great interest, and over the past decade much progress has been made to understand its composition, biosynthesis, and potential roles. However, several key aspects of this spore structure are still debated and remain undetermined. In this review, we focus primarily on the exosporium of B. anthracis and highlight important findings from the literature. A complete compilation and review of all the primary literature is beyond the scope of this article, and any failure to cite significant sources is unintended.
EXOSPORIUM COMPOSITION
The exosporium is the outermost integument surrounding the mature B. anthracis spore and is a loose-fitting, balloon-like structure. Although it appears to be loosely associated with the spore, the exosporium is not readily removed. Exosporium removal by physical means requires multiple passages through a French press; however, strain differences in ease of removal have been reported (6) .
The B. anthracis exosporium is composed of two layers: the outer-layer nap and the basal layer (Fig. 1) . The inner layer consists of a paracrystalline basal layer with a hexagonal lattice structure (3) . A more in-depth study of the exosporium crystal fragments has been performed from B. cereus, B. thuringiensis, and B. anthracis strains. From this study, three distinct crystal types were found between the various species (7) . The so-called type II crystals were common to all three Bacillus species examined and form the outermost layer of the exosporium. Type I crystals were rare in B. cereus and B. anthracis exosporium fractions. The type III crystals were found in all three Bacillus species but were the least frequently observed and their presence was dependent on the strain and method of spore preparation. The arrays formed by type I and II crystals would presumably form a semipermeable barrier around the spore. The barrier would include pores approximately 23 to 34 Å in diameter that would allow passage of germinants to the endospore but inhibit access of antibodies and enzymes (7) .
The exosporium of the Bacillus species is a biochemically complex structure that cross-reacts with lectins (8) and can bind to polysaccharides (9) . The B. cereus exosporium constitutes approximately 2% of the spore mass. Some, but not all, studies indicate that the exosporium is more hydrophobic than the spore coat, and the surface hydrophobicity of spores appears to depend mainly on components of the exosporium. In these analyses, spores having an exosporium are more hydrophobic than those lacking this structure (10) (11) (12) . In addition, the composition of the exosporium was determined to be approximately 50% protein, 20% lipid, 20% neutral polysaccharides, and 10% other components (9) .
Exosporium and spore coat proteins have the capacity to cross-link into high-molecular-weight complexes (13) (14) (15) (16) (17) (18) (19) . Over the past several years, numerous laboratories have purified the exosporium from different strains of B. anthracis and B. cereus, identifying the specific proteins composing this structure. Many of the same proteins identified were common between studies, but some differences have been noted that could be intrinsic or artifact due to the methods of bacterial growth, spore harvesting, exosporium purification, or analyses employed. Details of the various identified proteins will be discussed later in this chapter.
One of the first proteomic studies of the exosporium analyzed the Sterne 34F2 strain of B. anthracis (17) . The spores were prepared in Difco sporulation broth, washed, and separated from vegetative debris through a density gradient. The exosporium was purified after passage through a French press. Five major protein bands were identified by amino-terminal sequencing: alanine racemase, iron/manganese superoxide dismutase, BxpA, BclA, and BxpB (also referred to as ExsFA).
In contrast, the number of identified exosporium proteins was much greater in a separate study of the Sterne 34F2 strain of B. anthracis (20) . In this study, 137 exosporium proteins were identified. Several differences were noted between this study and the one described above. The B. anthracis strain was prepared and sporulated in G medium and, more importantly, spores were only water washed to better model environmental conditions in nature. The exosporium could potentially have protein and debris associated with and/or bound to it that might play some role in environmental persistence, transmission, or infectivity of the spores (21) .
Other studies identifying proteins of the exosporium expanded these observations to include multiple strains: the fully virulent Ames strain, an Ames derivative lacking pXO2, and a Sterne derivative (UM23CL2) lacking both pXO1 and pXO2 (22) . Spores were prepared on New Sporulation medium agar and water washed. The exosporium was purified following sonication rather than a French press procedure because of the equipment constraints and the potential for formation of aerosols within containment laboratories. Analysis of the exosporium proteins was performed on unwashed as well as salt-and detergent-washed proteins. As expected, many of the proteins identified from the unwashed exosporium contain vegetative cell proteins, such as EA1, an S-layer protein (23) . The washed exosporium preparations from the three strains listed above were used to identify those exosporium proteins that are tightly bound and integral to this structure. The proteins identified included BclA, alanine racemase, inosine-preferring nucleoside hydrolase, BxpB/ExsFA, CotB, CotY, ExsY, and ExsK. From this study, no differences were identified in the exosporium profile between the three strains examined (22) ; however, as discussed below, strain-related differences in the sizes of some exosporium proteins have been shown (16, 17, 24) .
A thorough study of the protein profile of the exosporium from the B. cereus strain ATCC 10876 has been reported (25) . The spores were prepared in CCY (casein hydrolysate yeast-containing) medium and purified by water washes. To obtain exosporium, the spores were processed twice through a French press. Then, the exosporial fragments were further purified and washed in salt and detergent. From the washed preparations, ten exosporium-associated proteins were identified: alanine racemase, nucleoside hydrolase, ExsB, ExsC, ExsD, ExsE, ExsF, ExsG, ExsJ, and CotE. Interestingly, in B. subtilis, CotE is a morphogenetic protein involved in spore coat assembly located between the inner and outer coat (26) . Only the N-terminal portion of the B. cereus CotE protein was found associated with the exosporium profile. The presence of CotE within the exosporium suggested a link between coat and exosporium assembly that has since been demonstrated (27) . In B. anthracis, CotE has been shown to play a role in exosporium assembly. Interestingly, in B. anthracis, CotE has been detected only within the spore coat (27, 28) . However, this does not discount the possibility of CotE being present in multiple locations of the spore. The role of CotE in the assembly of exosporium and spore coat is discussed in more detail below and by Driks and Eichenberger (108) .
EXOSPORIUM PROTEINS Collagen-Like Proteins BclA (Bacillus collagen-like protein A)
One of the first exosporium proteins to be identified and the most extensively studied to date is BclA (17, 18) . BclA is a complex glycoprotein and the structural constituent of the hair-like filaments on the outer layer of the exosporium (18) . BclA, along with other exosporium proteins, forms a covalently linked complex that is displayed as a very large-molecular-weight band when viewed on SDS-PAGE gels (13, 17-19, 22, 29-33) .
The BclA protein contains three domains: the N-terminal domain, the central region, and the carboxy-terminal domain (CTD). The N-terminal domain forms the proximal end of the BclA and is involved in targeting and anchoring the protein to the basal layer of the exosporium following a cleavage event (34, 35) .
The BclA central region is composed of GXX collagen-like repeats that are directly correlated with filament length, which can vary for strains from 140 to 608 Å (24) . Collagen-like sequences are rare in microorganisms but have been identified occasionally (36, 37) . However, antibodies to BclA were shown not to cross-react with human collagen (38) . The central region is the attachment site of two O-linked carbohydrate components: a 715-Da tetrasaccharide (three rhamnose residues, an unusual component termed anthrose, and a proteinbound N-acetylgalactosamine) and a 324-Da disaccharide (one rhamnose residue and 3-O-methyl rhamnose) (39) . The exact number of each oligosaccharide attached to BclA and the precise attachment sites on the protein remain to be determined. Anthrose was originally thought to be unique to B. anthracis; however, after further analysis, the sugar is more widespread than originally reported, because the genes and product are present in other Bacillus species (40) . The BclA-associated oligosaccharides account for most of the carbohydrate in the exosporium (39) .
The CTD of the BclA forms the distal end of the filament and is the immunodominant protein epitope on the intact spore surface, because most of the anti-BclA monoclonal antibodies generated against spores or exosporium react to the CTD (35) . However, antibody responses to anthrose-containing trisaccharide were found to be useful as a diagnostic for nonhuman primates that survived experimental pneumonic exposure to B. anthracis (41) . In addition, recombinant CTD trimers easily formed crystalline sheets that were resistant to elevated temperatures, detergents, and collagenases. It is the CTD of BclA that provides a rugged shield surrounding the spore (35) . Interestingly, it was determined that in the three-dimensional structure of BclA, the collagen-like N-terminal portion of the protein was disordered. In contrast, the CTD of BclA formed trimers as described above that would fold into a β structure with a "jelly roll" topology (42) . The folds made by the BclA crystal structure are similar to the tumor necrosis factor (TNF) family of proteins, especially C1q. While BclA does not possess many of the C1q activities, C1q functions as a bridge in the adherence of the BclA fibers to the integrin of epithelial cells (43) .
BclA may play a role in interacting with and recognizing hydrophobic components in the external environment or in the infected host. In fact, many studies have demonstrated that removing BclA from spores alters the overall hydrophobic, adhesive, and surface properties of the spore outer surface (11, (44) (45) (46) (47) (48) (49) . The details of many of these studies are discussed below.
BclB
BclB is a partially surface-exposed, collagen-like glycoprotein containing tandem repeats (50, 51) . Also, similar to BclA, BclB contains spore-specific sugars (rhamnose, 3-O-methyl rhamnose, and galactosamine) (51) and an N-terminal domain that targets the protein to the exosporium (50) . The role of the BclB protein continues to emerge. However, a bclB mutant strain has been constructed and spores of the mutant possessed a fragile exosporium. Electron microscopic observations of these spores revealed a mixed population: free exosporial basal layers, spores with damaged exosporia, as well as many spores with no visible defects to the exosporia (50) . The mutation did not affect spore germination or kinetics of spore survival within macrophages (50) .
BetA (Bacillus exosporium-targeted A)
The BetA protein was recently identified and found to contain a small collagen-like repeat region which exhibits strain-associated variation in the number of repeats. It is believed that BetA is located within the basal layer of the exosporium underneath the BclA protein (33) . It contains a conserved amino acid sequence in the N-terminal domain needed for targeting the protein to the exosporium (33) . Currently, the role of the BetA has not been defined.
ExsH and ExsJ
These collagen-like glycoproteins are present within the exosporia of B. thuringiensis (52) and B. cereus (21, 25) but have not been identified within B. anthracis. The proteins and their function have not been well characterized to date, but both contain a large region of GXX repeats. Recently, the impact of the exsH gene on the properties of the exosporium was examined in the B. cereus ATCC 14579 strain (48) . Spores of a mutant strain deleted for exsH demonstrated no visible changes to the exosporium basal layer or hair-like nap.
Exosporium Enzymes Superoxide dismutases (SODs)
The B. anthracis genome encodes for four superoxide dismutases that are enzymes capable of detoxifying oxygen radicals. Of these, two of the SODs (SOD15 and SODA1) are present within the exosporium (17, 20) . To determine if the exosporium SODs play a role in pathogenesis, a double mutant Δsod15 ΔsodA1 was constructed in the Sterne strain of B. anthracis by Cybulski et al. (53) . The mutant strain was slower to germinate and also was more sensitive to oxidative stress in comparison with the parental strain. However, no differences in virulence were determined between wild-type and mutant spores in the A/J mouse model of lethal Sterne infection. When a quadruple-SOD knockout strain was constructed (the two exosporiumassociated and two non-exosporium-associated SODs), spores of this mutant were attenuated in mice following intranasal challenge.
Alanine racemase (Alr)
The Alr enzyme converts L-alanine (a germinant) to the D-alanine form (a germination inhibitor) (54) . The Alr protein is present in the basal layer of the exosporium but not present within the "cap-like" region that serves as the region for the germinating bacillus to emerge during germination and outgrowth (6) . In addition, Alr is also present within the coat layer of the spore (29) . The Alr enzyme presumably suppresses spore germination in areas that would be inhospitable for vegetative cell survival, whether in the soil environment or in a host, until there is a level of germinant high enough to overcome the Alr activity (55) .
An alr deletion mutant was constructed in the Sterne strain of B. anthracis. Spores of the mutant strain were able to more efficiently germinate in low L-alanine environments in comparison with wild-type spores, since the Alr enzyme was not present to convert the germinant into the D-alanine form (56) . However, no difference was noted in germination rates with other germinants. A second, related role for Alr was also identified from this experiment. Alr appears necessary for producing mature, resistant spores by converting L-alanine to D-alanine within the mother cell. During sporulation, approximately half of the alr mutant spores converted from a phase bright/heat-resistant form to a phase dark/ heat-sensitive form.
IunH (inosine hydrolase)
Previous fractionation studies identified IunH in the exosporium (22, 25) . However, a separate study based on a green fluorescent protein fusion construct localized the protein to the interspace region, which is between the coat and the exosporium (5) . This enzyme presumably regulates the rate of inosine-induced germination and perhaps spore germination within macrophages.
Other Basal Layer Exosporium Proteins ExsY and CotY
The ExsY and CotY proteins are homologs of the B. subtilis coat proteins CotY and CotZ (57, 108) and were identified as components of the B. anthracis exosporium within the high-molecular-weight complex (22) . ExsY and CotY are paralogs and have ∼90% amino acid identity to one another, except for their Nterminal domains (13) . In B. cereus ATCC 14579, spores of the exsY mutant were missing the exosporium basal layer and the coat did not stain evenly by electron microscopy (EM) analysis, suggesting an effect on the spore coat. As such, the spores of exsY mutant were more sensitive to lysozyme than to wild type. Spores of a cotY mutant still contained an exosporium, although it appeared to be closer to the coat, in contrast to the larger distance between the coat and exosporium surrounding wild-type spores (13) .
The ExsY protein has also been investigated in the Sterne strain of B. anthracis. The ability of the exsY mutant to form an exosporium was dependent on culture conditions. When grown on solid media, spores of the mutant still formed an exosporium, based on reaction with an anti-BclA antibody. However, the labeling of the antibody was restricted to the polar caplike region of the spore. In contrast, when grown in liquid media, spores of the mutant did not possess an exosporium (29) . Interestingly, in comparison with the results with spores of the B. cereus exsY mutant (13), the B. anthracis exsY mutant was not sensitive to various environmental stresses, including exposure to lysozyme (29) .
ExsA
The ExsA protein of B. cereus was identified in a transposon mutagenesis study by enriching for spores that were less hydrophobic following exposure to a hexadecane/ aqueous-phase partitioning system (10) . The ExsA protein is the equivalent of SafA (YrbA) of B. subtilis, which has a role in spore coat assembly (58) . In B. cereus, the ExsA protein contains an N-terminal region that shows 86% identity to B. subtilis SafA over the first 49 amino acids. In contrast to SafA, the ExsA protein contains multiple tandem oligopeptide repeats. The ExsA protein was examined in detail in B. cereus ATCC 10876 in which the gene was inactivated. In spores of the mutant, the exosporium was thinner, looser, and irregularly shaped. Many spores were also observed lacking any associated exosporium. In addition, the spore coat was similarly affected in an exsA mutant. By EM observations, some spores lacked a spore coat, whereas others had a partially assembled spore coat. Not surprisingly, the spores of the exsA mutant were very sensitive to lysozyme and overall were less stable compared with wild-type spores. The gene encoding the ExsA protein is also present in the B. anthracis genome (59); however, the protein has not been examined to date. Nevertheless, it is hypothesized to play a role similar to that observed in B. cereus.
BxpA
The BxpA protein was originally identified by Steichen et al. (17) and Liu et al. (20) as an exosporium protein and has many interesting characteristics. Only the carboxy-terminal fragment of this protein was found within the exosporium profile, suggesting proteolysis. The location of the amino-terminal portion of BxpA was not determined. The protein displayed a highly unusual amino acid composition with 54 glycine and 38 proline residues. In addition, the protein is composed of three pairs of identical tandem repeats. The BxpA proteins from the Ames and Sterne strains of B. anthracis differ by a noted 14-bp codon deletion in the Sterne strain (17) . A second study utilized immunoelectron microscopy to localize the majority of the BxpA protein to the spore cortex and not the exosporium of Ames spores (16) . One potential reason for these differing results between studies is that BxpA may be present both in the exosporium and associated with the cortex, but the concentration of exosporium-associated BxpA may be below the limit of detection of immune-electron microscopy. The presence of spore proteins in multiple locations is not unprecedented (25, 30, 60) .
Moody et al. (16) described that the maturation of BxpA depends on the proteins YabG and Tgl. It appears that YabG proteolyzes and Tgl cross-links BxpA. Similarly, several B. subtilis coat proteins are cleaved during or after assembly (61) (62) (63) . At least some of this proteolytic processing is under the control of YabG (58, 61, 63) . Spore proteins can also be modified through crosslinking. It has been shown that at least some coat protein cross-linking is controlled by the coat-associated transglutaminase Tgl (14, 64, 65) . The discovery of roles for YabG and Tgl in BxpA maturation is consistent with the possibility that, as in B. subtilis, YabG cleaves and Tgl cross-links B. anthracis spore proteins.
ExsFA/BxpB and ExsFB
The ExsFA/BxpB and ExsFB proteins are part of the high-molecular-mass spore protein complex. These proteins are required for localization of the BclA protein on the spore surface (5, 19, 31, 66) and stability of the exosporium crystalline layers (19) . The ExsFA/BxpB protein has been localized to the basal layer of the exosporium (5, 31) . In contrast, ExsFB is located in the interspace region of the spore between the spore coat and the exosporium (5) .
ExsM
ExsM is a small basic protein that was identified from a proteomic analysis of the exosporium of B. cereus strain ATCC 4342 (67) . When the exsM gene was inactivated, spores of the mutant were morphologically different. In the parental strain, the exosporium was elongated. In contrast, the exsM mutant spores had the exosporium more closely associated to the cell, and the spores were significantly shorter. In addition, spores lacking the ExsM protein were encased in two distinct exosporium layers with the hair-like nap present on each of the exosporium layers facing the exterior. The double exosporium spores were more resistant to treatment with lysozyme, which is consistent with the exosporium being a semipermeable barrier to macromolecules. The double exosporium spores were also altered in their germination kinetics. Specifically, the exsM spores showed an initial low rate of germination in the presence of L-alanine. The authors theorized that the escape mechanism of the cell may not be forceful enough to rapidly burst from the double exosporium.
The spores of an exsM-deficient mutant in the B. anthracis ΔSterne strain were shorter and rounder than those of the wild-type parent strain. The exosporium of the mutant was partially or fully detached from the spores, and approximately 30% of the mutant spores had altered exosporia (either partial or double exosporium) (67).
ExsK
The ExsK protein was initially identified in exosporium proteomic studies (20, 22, 25) and further characterized by Severson et al. (30) in the Sterne and Ames B. anthracis strains. It is part of the BclA-associated high-molecular-weight exosporium protein complex. Also, by microscopy, ExsK was found in two distinct locations of the spore. ExsK is on the outside of the exosporium basal layer, but its recognition by antibody is partially blocked by the presence of BclA. In addition, when examining spores of the cotE mutant that lack an exosporium (27) , ExsK was still detected on the surface. These data suggest that ExsK is both on the exosporium surface and within the spore, beneath the exosporium.
To determine the role of ExsK in B. anthracis, mutant strains were constructed. Ames exsK mutants were tested in two different animal modes of infection. However, no loss of virulence was detected (30) . When germination was measured by a fluorescent-dye uptake assay (68) , the exsK mutant spores germinated slightly but significantly faster than wild-type spores. The exact mechanism of this effect of ExsK on germination remains to be determined.
EXOSPORIUM BIOSYNTHESIS
Assembly of the B. anthracis spore coat and exosporium is still poorly understood, although this has been an active area of interest. Many coat proteins are conserved between B. anthracis and the more thoroughly studied B. subtilis, suggesting some overlap in the mechanism controlling coat assembly (69, 70) . In addition, in the B. cereus family, some homologs of B. subtilis spore proteins function in both coat assembly and formation of the exosporium (10, 13, 27, 29) .
The exosporium proteins first appear during stage III of sporulation, and the exosporium is observed as a small lamellar structure in the mother cell cytoplasm that is synthesized concurrently with the spore coat (71, 72) . The SpoIVA protein, which is important for directing assembly of the coat to the B. subtilis forespore (73) , is similarly responsible for assembly of the B. anthracis coat and indirectly exosporium (27) . Bacilli of B. anthracis spoIVA mutants were able to enter sporulation normally but were never able to progress through sporulation. Swirls of material were observed within the mother cell that likely contained both coat and exosporium material (27) . Thus, the proteins required for spore production were present within the mother cell, but assembly was severely impacted.
In B. subtilis, the CotE protein is a major morphogenetic protein responsible for assembling the outer coat proteins (26) . In contrast, when the cotE gene is mutated in B. anthracis, the resulting spores have a significant but limited defect in the spore coat. Only minor changes were observed by EM observations to the coat and spore protein profile. In addition, spores of the B. anthracis cotE mutant did not become sensitive to lysozyme. The exosporium of the cotE mutant is synthesized but fails to encircle and attach to the forespore during sporulation (27) .
CotE may direct the synthesis of other proteins involved with exosporium biosynthesis, ExsY and CotY. These proteins are orthologs of CotE-controlled protein, CotZ, in B. subtilis (74) . In B. cereus, ExsY and CotY are both necessary for proper coat and exosporium formation (13) . If the exsY gene in B. anthracis is mutated, the exosporium production is affected where only a caplike fragment assembles onto one end of the forespore closest to the mother cell midpoint (29) . Perhaps ExsY then directs the remainder of the polymerization of the sheet of the exosporium shell to close upon itself.
In a bclA mutant strain of B. anthracis, the BclB protein is also localized at the exosporium cap (50) . Likewise, the integrity of the exosporium of a bclB mutant is compromised, leading the structure to slough off the spore (50, 51) . During sporulation, the BclA protein and exosporium basal layer localize to the central pole of the forespore. The N-terminal domain of BclA is required for targeting and incorporating this protein into the exosporium basal layer following cleavage and release of 19 amino acids (34) .
Other proteins shown to be involved in correct assembly of BclA into the exosporium are ExsFA/BxpB and ExsFB. Mutations of these corresponding genes lead to spores that are devoid of or decreased in the amount of the hair-like nap that extends from the exosporium basal layer (5, 19, 31, 66) . Likewise, Giorno et al. (5) reported that in an exsFA/bxpB mutant, BclA accumulates at the mother cell pole of the forespore. Further data demonstrate that BclA and ExsFA/BxpB are coexpressed, form a complex, and then localize to the mother cell-central pole of the spore. As the exosporium continues to enclose the spore, BclA is glycosylated and the N-terminal 19-amino-acid peptide is cleaved from BclA (66).
FUNCTION OF THE EXOSPORIUM IN GERMINATION
Spore germination is a somewhat paradoxical phenomenon, in that spores must remain resistant to chemical and physical insults; however, spores must also be prepared to germinate upon introduction of germinants, such as L-alanine, inosine, etc. (75) . Germination is essential to the pathogenesis of B. anthracis and subsequent disease. Spores that have altered germination potential result in significantly different pathology and outcomes of infection (55, 76) . Much work has been accomplished trying to understand germination (see Popham and Bernhards [109] ); however, many facets of germination still remain uncertain. In particular, the role of the exosporium in spore germination remains rather undefined.
Germinant receptors are present in the inner spore membrane, several layers beneath the exosporium. Perhaps an additional function of the exosporium is to dictate which molecules/compounds or what concentrations of these potential germinants come into contact with the spore. The exosporium basal layer is somewhat permeable. Early studies by Gerhardt and Black indicated that the exosporium is clearly permeable to small molecules. Based on modeling criteria at that time, the pore sizes ranged from 10 to 200 Å, and these pore sizes were thought to be uniform across the exosporium surface (77) . More recently, Ball and coworkers detailed the structure of the exosporium based on data generated through crystallography (7) . In these studies, the exosporium was demonstrated to contain pores ranging in size from 23 to 34 Å (7) . This size pore would be large enough for germinants, such as inosine and L-alanine, to permeate but would be restrictive to potentially degradative enzymes or host-generated antibodies (7) . However, it has been shown that anti-whole-spore antibodies have a germination inhibitory activity (68, 78) ; these antibodies could possibly interact with structural components of the exosporium, block the pores, and subsequently interfere with the translocation of potential germinants across this structure. While this inhibition of germination is largely transient, these antibodies significantly alter the germination potential of B. anthracis spores. These antibodies have also been shown to be opsonic in in vitro assays (potentially altering the sporemacrophage interactions) (60, 79) and anti-spore antibodies provided limited passive protection to mice, suggesting that these antibodies are potentially protective, as described in more detail below (60, 79) .
The impact of specific exosporium structural components on germination has been difficult to ascertain. For example, Bozue et al. demonstrated that there were no significant differences associated with the rate or extent of germination in ΔbclA versus wild-type Ames spores (44) . These results were confirmed using two different assays for germination (fluorometric and loss of absorbance). However, Brahmbhatt et al. reported that ΔbclA spores germinated slightly (but significantly) better than Sterne wild type (11) . One study used a fully virulent strain of B. anthracis, whereas the other used the attenuated Sterne strain of B. anthracis. Additionally, there were variations in procedures employed that make these data difficult to compare directly. Giorno et al. demonstrated that spores devoid of ExsFA/BxpB exhibited a modest but significant defect in a potentially early step in germination (5) . However, Steichen at al. reported that their version of these mutant spores germinated better than the parental strain (31) . Again, there is enough variation between these studies to make direct comparisons of subtle germination phenotypes challenging. Removal of the ExsA protein, another exosporium protein from B. cereus with a homologue in B. anthracis, appeared to slow germination in comparison with wild-type spores (10) . It has also been reported that exsK mutant spores of B. anthracis germinate more rapidly than wild-type spores (30) .
Other exosporium proteins may not be structural proteins, but are thought to be tightly adsorbed and accordingly integrated into the exosporium. Examples of this phenomenon include a nucleoside hydrolase and an alanine racemase (25, 80) . Inosine may act as a primary germinant for B. cereus and B. thuringiensis (inosine induces significant spore germination in the absence of other germinants) and a cogerminant for B. anthracis (inosine significantly lowers the required concentration of a primary germinant, such as L-alanine). The nucleoside hydrolase would degrade inosine, thus regulating environmental levels and potentially lessening the impact of inosine as a cogerminant. L-Alanine is an important germinant for both B. anthracis and B. cereus. The alanine racemase is thought to, in part, regulate germination in several instances. The enzymatic activity of alanine racemase involves converting L-alanine (germination trigger) to D-alanine (germination inhibitor). Thus, this enzyme can manipulate L-alanine concentrations to ensure germination is only initiated when conditions are desirable. When alanine racemase activity has been inhibited, B. cereus spores germinate more readily (81, 82) . It has been proposed that this alanine racemase activity may be part of a germination-inducing quorum-sensing mechanism in B. cereus (81) . In these studies, the authors demonstrated that B. cereus germination was enhanced by higher spore concentrations and conditioned medium (81) . This conditioned medium contained L-alanine released by previously germinated spores. This quorum sensing has not been observed in B. anthracis, presumably because B. anthracis spores do not release amino acids, and under normal conditions, require two germinants (e.g., a germinant and a cogerminant) to germinate (81) . Additionally, it has been documented that B. anthracis spore germination rates are negatively impacted by higher spore densities in vitro (83) .
In the case of B. anthracis, Alr activity plays a role in spore-macrophage interactions (55, 82, 84) . While cogerminants are necessary for optimal germination of B. anthracis spores, the Alr enzyme is sufficient to inhibit germination induced by L-alanine. In mouse models of anthrax, the importance of appropriately timed germination is underscored, because spores with altered germination profiles result in significantly different disease progression (55, 76) . Additionally, Chesnokova and colleagues have shown that Alr activity prevents germination of late-stage spores within the sporulating mother cells, suggesting that this enzymatic function is also necessary to prevent premature germination during sporulation, thus ensuring the production of environmentally stable endospores (56, 82, 84) .
The "cap-like" region of the exosporium is at one pole of the spore and serves as the exit route of the outgrowing cell during germination. The "cap-like" region corresponds to the area where the exosporium begins assembling, as described above, within the mother cell during sporulation. In a mature spore, this area of the exosporium does not bind anti-Alr monoclonal antibodies, demonstrating that exosporium assembly is not a uniform process. The germinating cells always escape through the exosporium by popping through the cap with enough force to allow the cell to rapidly and completely separate from the exosporium. Perhaps this escape from the spore is important for the vegetative cells when facing the in vivo environment and host's immune cells (6) .
ROLE OF EXOSPORIUM IN VIRULENCE
The role of the exosporium in virulence, especially for the BclA protein itself, has been a topic of great interest. When examining B. anthracis spores lacking the complete exosporium, as generated from cotE mutant spores in the Ames strain, no difference in virulence was detected following intramuscular challenge in guinea pigs or intranasal challenge in mice (27) . These challenges were performed by using low doses of the spores, and no difference was noted in comparison with the challenge with wild-type Ames spores. However, median lethal dose (LD 50 ) analyses were not performed with the exosporium minus strain. In addition, genetic mutants of the Ames strains have been constructed that lack the nap-like fibers but retain the exosporium basal layer, and no differences in virulence have been detected through multiple animal B. anthracis challenge models (5, 44) . Similar results were first described with a bclA mutant in the Sterne strain of B. anthracis following subcutaneous challenge in mice (18) . Other studies indicate that lack of the BclA fibers in the Sterne vaccine strain render the mutant more virulent than the parental strain as determined through differences in mean time to death or LD 50 measurements (11, 49) . It can be concluded that the BclA protein or the complete exosporium structure is not needed for B. anthracis spores to remain virulent in animal models of anthrax. While BclA is certainly immunodominant and accordingly an attractive target for vaccine and detection technologies, this protein could easily be removed from a B. anthracis variant engineered to subvert vaccine efficacy or evade detection systems yet retain full virulence. Thus, a multiantigen vaccine strategy, making vaccine subversions difficult, would be ideal.
INTERACTION OF THE EXOSPORIUM WITH HOST CELLS
Several lines of evidence indicate that the BclA fibers play a critical role in targeting spores to mammalian phagocytes. Using a bclA mutant in the Ames strain, Bozue et al. (45) demonstrated that spores lacking the fibers were significantly more adherent to epithelial, fibroblast, and endothelial cells than spores of the parental wild-type strain (Figs. 2 and 3) . In contrast, no difference in spore binding to macrophages was detected (45) . Furthermore, BclA was shown to be the ligand for the integrin Mac-1 receptor on phagocytes (49) . Oliva and coworkers subsequently demonstrated that CD14 acts as coreceptor for spores in the Mac-1 pathway. It was shown that CD14 binds to rhamnose residues within the BclA protein and significantly enhances the internalization of spores via this Mac-1-dependent mechanism (85) . Interestingly, the relationship between rhamnose and spore-macrophage interactions had been shown previously; however, the reasons for these observations were unclear at that time (46) . Taken together, these results demonstrate that the BclA fibers may inhibit nonspecific interactions between B. anthracis spores with nonprofessional phagocytic cells and direct the spores toward uptake by phagocytes during infection.
In addition to its perceived role in attachment to macrophages, the exosporium may play a role in the survival of the spore once engulfed by macrophages. In one study, murine peritoneal macrophages were infected with Sterne 34F2 spores with or without an exosporium (removed by sonication). The sonicated spores (exosporium deficient) did not survive as well intracellularly as spores retaining exosporia (86) . The method by which the spores evade killing remains to be determined. However, recent evidence suggests that the exosporium may play a role in inhibiting the macrophage-oxidative burst. The presence of arginase within the exosporium has been demonstrated by several studies (22, (87) (88) (89) . The arginase activity of the exosporium may affect the nitric oxide production of the macrophage (87) . The efficiency of spore killing was further increased by macrophages when pretreated with interferon-γ (IFN-γ). In contrast, if the exosporium-deficient spores were opsonized with immune-IgG (collected from a serum sample from a human who had received the United Kingdom-licensed anthrax vaccine), no differences were observed in macrophage killing between treated and untreated sonicated spores. These data suggest that there is a target for IgG on the exosporium. Other investigators have observed the presence of the protective antigen (PA) associated with B. anthracis spores, which leads to increased uptake and killing by macrophages (68, 79, 90) .
Further evidence indicates that the exosporium structure may play a role during the interaction between spores and macrophages based on the cytokine response of the macrophage. When Sterne spores lacking an exosporium (removed by sonication) were added to macrophages, the cytokine mRNA response was significantly upregulated for IFN-β, interleukin-1β (IL-1β), TNF-α, and IL-6 in comparison with spores containing an intact exosporium (91) . The exact means by which the exosporium inhibits the cytokine response remains undetermined. It is possible that the exosporium cloaks structures that lead to the cytokine induction or enzymes are present within the exosporium that potentially alter the response.
A recent study has demonstrated that plasminogen was able to bind to the outer surface of B. anthracis spores (92) . If the exosporium was removed, little plasminogen was observed to bind to the spores. Plasminogen is a central component of the fibrinolytic system and is activated to plasmin. Once activated, it can degrade extracellular and matrix and basal layer proteins. The metalloprotease InhA, located within the exosporium (93) , can accelerate the activation of plasminogen.
In addition, BclA has also been shown to bind the pulmonary surfactant SP-C (42) , further suggesting that BclA may be used for targeting host cells. B. anthracis spores may also interact with lung epithelial cells during infection (94, 95) and the receptor for entry is the integrin α2β1 (43) . Recent work has demonstrated that BclA is required for spores to enter epithelial cells (43) . However, other reports have shown that spores lacking BclA are readily able to gain entry within nonprofessional phagocytic cells (45, 49) . BclA also appears to interact with the complement component C1q to bind to α2β1 (43) on epithelial cells (43) .
EXOSPORIUM AS A VACCINE TARGET
While the current and next-generation anthrax vaccines are effective, they target primarily only a single protein, PA (96) . PA is responsible for translocation of the toxin effector molecules (edema and lethal factors) into the cytosol of host cells (97) . Antibody against PA interferes with this process and as a result prevents significant intoxication of the host. However, there are several drawbacks associated with this strategy. Since these vaccine strategies are antitoxin, essentially the bacteria are permitted to infect the host until the antitoxin vaccine begins to take effect. Additionally, from a biodefense perspective, it would be beneficial to have a multicomponent anthrax vaccine to combat emerging or engineered threats that may be refractory to current vaccine approaches (98, 99) . Because the exosporium is the outermost surface of a B. anthracis spore and a source of numerous antigens of vaccine targets, the exosporium has been the focus of numerous novel vaccination approaches. Accordingly, several laboratories have investigated the concept of vaccines based on inactivated spores or spore structures, such as the exosporium.
The most promising data indicating protection attributed to an anti-spore immune response have been generated by vaccinating small animals with formaldehyde-inactivated spores (FIS). Brossier and colleagues demonstrated that vaccine formulations containing PA and FIS provided significantly greater levels of protection in mice and guinea pigs when compared with vaccination with PA alone (100) . These studies involved parenteral challenge routes. These observations were confirmed by Gauthier and coworkers who utilized similar vaccine formulations; however, the mice and guinea pigs in this study were challenged with virulent spores delivered via the inhalation route (both intranasal instillation and aerosol delivery) (101) . In these studies, it was demonstrated that by targeting both the earliest phase of infection (entry of ungerminated B. anthracis into hosts) and also the later stage of infection (intoxication), the experimental animals were more likely to survive infection with lethal doses of B. anthracis. These observations were consistent among studies regardless of the infection route.
Cote et al. presented data suggesting that mice vaccinated with irradiated spores were more likely to survive an infection with aerosolized B. anthracis spores compared with unvaccinated controls (102) . It was demonstrated that irradiated Ames strain spores and irradiated ΔbclA spores offered similar levels of protection to the mice following a challenge with a low dose of aerosolized Ames spores. These data suggested other non-BclA epitopes associated with irradiated spores may be somewhat protective (102) . Of more recent note, Vergis et al. (103) demonstrated that immunization with FIS from nontoxigenic and nonencapsulated B. cereus provided significant levels of protection to mice challenged with the Ames strain of B. anthracis. These studies demonstrated that this protection was independent of PA or BclA being present in the vaccine. In an ideal situation, whole killed spores would be replaced in vaccine formulations with a defined individual or group of protective epitopes. Recombinant exosporium components have been shown to augment the efficacy of a PA vaccination. Brahmbhatt et al. demonstrated that the immune responses generated in mice receiving a single suboptimal injection of PA were significantly augmented by a later injection of BclA (38) and that the mice receiving both antigens were better protected against a lethal Sterne spore challenge than those receiving either PA or BclA alone. These results were similar to those published earlier by Hahn et al. (104) . In the latter studies, it was demonstrated that vaccination with a DNA construct encoding PA in combination with a construct encoding BclA was superior in efficacy to vaccination with PA constructs alone (104) . Hahn et al. demonstrated partial protection against challenge with the fully virulent Ames strain.
It has also been shown that other immunogens besides BclA may offer an advantage to vaccinated animals. Cybulski and colleagues observed significant protection when ExsFA/BxpB or p5303 (a hypothetical protein associated with the exosporium of B. anthracis) was used in vaccine formulations (105) . The same recombinant exosporium components (BclA, ExsFA/BxpB, and p5303) significantly improved the outcome of infection in mice and guinea pigs (102) . These resulting anti-exosporium component antibodies augmented protection of both mice and guinea pigs when challenged with ΔAmes (pXO1 -/ pXO2 + ) and fully virulent Ames, respectively (102) .
Data from passive protection studies performed using antisera generated against whole spores have been less impressive. It was previously reported that passive transfer of rabbit anti-spore antibodies could significantly protect mice against challenge with a fully virulent strain of B. anthracis (78) . The antibodies used were generated in rabbits against a strain of B. anthracis that was cured of both pXO1 and PXO2, so that antibodies would be elicited against spore structures (presumably the surfaceexposed exosporium layer) and not against either toxin components or capsule. In contrast, Glomski et al. could not demonstrate significant levels of passive protection when mouse immune FIS sera were transferred to naïve mice (106). Cote et al. later demonstrated that slight protection was afforded by passive transfer of rabbit anti-irradiated spore IgG into naïve mice, but this protection was only statistically significant when compared with completely naïve mice (60) . When the survival was compared with mice receiving normal rabbit IgG, the observed protection was statistically insignificant, suggesting that some of the protection was not spore specific. When taken together, these data indicate that there are trends toward protection afforded by passive transfer of anti-spore antibodies; however, these trends lack reliable statistical significance.
Augmented protection afforded by an active anti-spore immune response has been detailed by several laboratories; however, this protection was not reproduced in passive protection studies, suggesting a mechanism that may not be completely antibody mediated. These data encouraged Glomski et al. to further investigate the mechanisms associated with the added protection offered by FIS when added to a PA vaccine regimen (106) . These authors elegantly demonstrated a cellular component to this antispore immunity. When splenocytes harvested from FIS immune mice were transferred to naïve mice, significant protection was achieved. Through further experimentation using transgenic animals and in vivo lymphocyte depletion methodology, it was demonstrated that INF-γ-producing CD4 lymphocytes were, in part, responsible for the vaccine augmentation associated with FIS (106) .
Regardless of the exact mechanism associated with the augmented levels of protection, this body of evidence clearly demonstrates that an anti-spore, in particular, an anti-exosporium immune response, benefits the vaccinated host. Efforts to more precisely elucidate these benefits are needed so as to further optimize current anthrax vaccine strategies as well as to increase preparedness against future emerging and/or engineered threats.
CONCLUSIONS
Over the past decade, great strides have been made in better understanding the composition and biosynthesis of the exosporium of B. anthracis. Although insights have been gained regarding the interaction of the exosporium with the host during infection, the exact roles and significance of this complex structure remain to be determined. Because this is the outermost structure of the spore and affects adherence to mammalian cells, the exosporium most likely plays a role for persistence in the natural soil environment, as recent evidence indicates (107) . Furthermore, because the exosporium is a highly antigenic structure, future strategies for the next-generation anthrax vaccine should pursue its inclusion as a component to provide protection against the spore itself during the initial stages of anthrax.
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